[Clinical experience with urokinase therapy].
Clinical Experience with the Urokinase Therapy Although all the biochemical details of fibrinolytic therapy are not yet clear, this type of treatment has found its place. Due to its lower risk of haemorrhage and non-existent allergenic properties urokinase is usually preferred and in certain cases must be used exclusively, although it is still the more expensive. It is to be hoped, that the promising experiments for cheaper production of urokinase by bacteria, will bring financial relief.
D005342:Fibrinolysis / Q000187:drug effects; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D013300:Streptokinase / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Klinische Erfahrungen bei der Urokinase-Behandlung.